Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1).

[1]  R. Oballa,et al.  Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series. , 2012, Bioorganic & medicinal chemistry letters.

[2]  David A. Powell,et al.  Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia. , 2011, Journal of medicinal chemistry.

[3]  C. Steppan,et al.  N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[4]  M. Yamada,et al.  Synthesis and evaluation of novel stearoyl-CoA desaturase 1 inhibitors: 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-3,4-dihydrospiro[chromene-2,4'-piperidine] analogs. , 2010, European journal of medicinal chemistry.

[5]  J. Falgueyret,et al.  Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438). , 2010, Bioorganic & medicinal chemistry letters.

[6]  J. Guay,et al.  Thiazole analog as stearoyl-CoA desaturase 1 inhibitor. , 2009, Bioorganic & medicinal chemistry letters.

[7]  M. Yamada,et al.  Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation. , 2009, Bioorganic & medicinal chemistry letters.

[8]  A. I. Glushkov,et al.  Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[9]  H. Sham,et al.  Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[10]  J. Ntambi,et al.  Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism , 2008, Current opinion in lipidology.

[11]  M. Miyazaki,et al.  Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. , 2007, Cell metabolism.

[12]  Manabu T. Nakamura,et al.  STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES , 2004 .

[13]  J. Friedman,et al.  Identification and Characterization of Murine SCD4, a Novel Heart-specific Stearoyl-CoA Desaturase Isoform Regulated by Leptin and Dietary Factors* , 2003, Journal of Biological Chemistry.

[14]  M. Miyazaki,et al.  Recent insights into stearoyl-CoA desaturase-1 , 2003, Current opinion in lipidology.

[15]  M. Miyazaki,et al.  Role of stearoyl-coenzyme A desaturase in lipid metabolism. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[16]  F. Zintl,et al.  Fatty acid composition of lymphocyte membrane phospholipids in children with acute leukemia. , 2001, Cancer letters.

[17]  M. Miyazaki,et al.  Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. , 2001, The Journal of nutrition.

[18]  M. Miyazaki,et al.  The Biosynthesis of Hepatic Cholesterol Esters and Triglycerides Is Impaired in Mice with a Disruption of the Gene for Stearoyl-CoA Desaturase 1* , 2000, The Journal of Biological Chemistry.

[19]  R. Solà,et al.  Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury. , 2000, Arthritis and rheumatism.

[20]  J. Ntambi.  Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. , 1999, Journal of lipid research.

[21]  B. Spiegelman,et al.  Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. , 1993, The Journal of biological chemistry.

[22]  E. Kraegen,et al.  Influence of Dietary Fat Composition on Development of Insulin Resistance in Rats: Relationship to Muscle Triglyceride and ω-3 Fatty Acids in Muscle Phospholipid , 1991, Diabetes.